Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Jacob Schachter
Based on 65 articles published since 2009
(Why 65 articles?)
||||
Expertise Level
The expertise of Jacob Schachter ranks in the
  • Top 0.059%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 65 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Schachter, Jacob   ·   Schachter, J
Work Locations
Details
Most likely:    Tel Aviv University      
2019
  • Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · European Institute of Oncology IRCCS, Milan, Italy. · Auckland City Hospital, Auckland, New Zealand. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Brisbane, Queensland, Australia. · Aarhus University Hospital, Aarhus, Denmark. · Ella Lemelbaum Institute for Melanoma, Sheba Medical Center at Tel HaShomer, Cancer Center (Oncology Institute), Ramat Gan, Israel. · IRCCS San Martino-IST, Genova, Italy. · Melanoma Institute Australia and the University of Sydney, Mater and Royal North Shore Hospitals, Sydney, New South Wales, Australia. · Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. · Herlev Hospital, University of Copenhagen, Herlev, Denmark. · Sharett Institute of Oncology, Hadassah Hebrew Medical Center, Jerusalem, Israel. · Rambam Health Care Campus, Haifa, Israel. · Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec, Québec, Canada. · Novartis, East Hanover, NJ, USA. · Merck & Co., Inc., Kenilworth, NJ, USA. · University of California Los Angeles and the Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Pubmed 31171878
  • From Institut Gustave Roussy and Paris-Sud-Paris-Saclay University, Villejuif (C.R.), Aix-Marseille University, Marseille (J.J.G.), and Assistance Publique-Hôpitaux de Paris Dermatology and Clinical Investigation Center, Unité 976, Université de Paris, Hôpital Saint-Louis, Paris (C.L.) - all in France · Moscow City Oncology Hospital, Moscow (D. Stroyakovskiy), and the Petrov Research Institute of Oncology, St. Petersburg (E.L.) - both in Russia · Przychodnia Lekarska Komed, Konin (B.K.), the University of Medical Sciences, Poznań (A.M.), and the Maria Skłodowska-Curie Institute-Oncology Center, Warsaw (P.R.) - all in Poland · the University Hospital Schleswig-Holstein, Kiel (A.H.), the Department of Dermatology, University of Tübingen, Tübingen (C.G.), University Hospital Essen, Essen (D. Schadendorf), and the German Cancer Consortium, Heidelberg (D. Schadendorf) - all in Germany · the Veneto Institute of Oncology, Padua (V.C.S.), and Papa Giovanni XXIII Hospital, Bergamo (M.M.) - both in Italy · the Ella Lemelbaum Institute for Immuno-Oncology and Melanoma, Sheba Medical Center, Tel Hashomer (J.S.), and Sackler Medical School, Tel Aviv University, Tel Aviv (J.S.) - both in Israel · Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine (I.B.) · Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens (H.G.) · the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.) · Mount Vernon Cancer Centre, Northwood, United Kingdom (P.D.N.) · the University of California, Los Angeles, Los Angeles (A.R.) · the University of Texas M.D. Anderson Cancer Center, Houston (M.A.D.) · Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (K.T.F.) · Novartis Pharma, Basel, Switzerland (P.B.) · Novartis Pharmaceuticals, East Hanover, NJ (M.T., E.G., M.V.) · and the Melanoma Institute Australia, the University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.). · Pubmed 31166680
2018
  • The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · University of California, Los Angeles, Los Angeles, CA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Princess Alexandra Hospital, Brisbane, Australia. · University of California, San Francisco, San Francisco, CA, USA. · Hospital Clinic de Barcelona, Barcelona, Spain. · Edinburgh Cancer Research Centre and Western General Hospital, Edinburgh, Scotland, UK. · Medical University of Vienna, Vienna, Austria. · Centre Hospitalier Régional Universitaire de Lille, Université Lille, Lille, France. · Ella Lemelbaum Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel. · Merck & Co., Inc, Kenilworth, NJ, USA. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · Pubmed 30202085
  • Richard D. Carvajal and Gary K. Schwartz, Columbia University Medical Center · Paul B. Chapman and Alexander N. Shoushtari, Memorial Sloan Kettering Cancer Center, New York, NY · Sophie Piperno-Neumann and Manuel J. Rodrigues, Institut Curie, Paris · Lauris Gastaud, Centre Antoine-Lacassagne, Nice, France · Ellen Kapiteijn, Leiden University Medical Center, Leiden, the Netherlands · Stephen Frank, Hebrew University Hadassah Medical School - The Sharett Institute of Oncology, Jerusalem · Jacob Schachter, Sheba Medical Center at Tel Hashomer, and Tel-Aviv University Medical School, Tel Aviv, Israel · Anthony M. Joshua, Princess Margaret Cancer Centre, Toronto, ON, Canada · Josep M. Piulats, Institut Catala d'Oncologia L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain · Pascal Wolter, University Hospitals Leuven, Leuven, Belgium · Veronique Cocquyt, Ghent University Hospital, Ghent, Belgium · Bartosz Chmielowski, University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA · T.R. Jeffry Evans, University of Glasgow, Glasgow · Delyth Clemett, Shirley Spratt, Susan Lovick, and Elaine Kilgour, AstraZeneca, Macclesfield · Dana Ghiorghiu and Gabriella Mariani, AstraZeneca, Cambridge · Paul Nathan, Mt Vernon Cancer Centre, Northwood, United Kingdom · Gerald Linette, Washington University School of Medicine, St Louis, MO · Carola Berking, University Hospital of Munich, Munich, Germany · Peter Barker, AstraZeneca, Gaithersburg, MD · and Zhongwu Lai, AstraZeneca, Waltham, MA. · Pubmed 29528792
  • Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel. Electronic address: · Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Israel. · Division of Oncology, Sheba Medical Center, Ramat-Gan, Israel. · Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel. · Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel; Department of Oncology, Sackler Faculty of Medicine, Tel Aviv University, Israel. · Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Israel; Talpiot Medical Leadership Program, Sheba Medical Center, Ramat-Gan, Israel. · Pubmed 30096703
  • Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Ramat-Gan, 5262620, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Ramat-Gan, 5262620, Israel. · Institute of Pathology, Sheba Medical Center, Ramat-Gan, 5262620, Israel; Talpiot Medical Leadership Program, Sheba Medical Center, Ramat-Gan, 5262620, Israel. · Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Ramat-Gan, 5262620, Israel; Talpiot Medical Leadership Program, Sheba Medical Center, Ramat-Gan, 5262620, Israel. · Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Ramat-Gan, 5262620, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; School of Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: · Pubmed 29558679
  • Aix Marseille University and APHM University-Hospital Marseille France, France. Electronic address: · University of Essen and German Cancer Consortium, Heidelberg, Germany. · University of Manchester, Christie National Foundation Trust Manchester, UK. · Istituto Nazionale Tumori - Fondazione "G. Pascale", Napoli, Italy. · Royal Marsden Hospital, London, UK. · Mount Vernon Cancer Centre, UK. · Gustave Roussy and Paris-Sud University, Paris, France. · Universitätsklinikum Schleswig-Holstein, Kiel, Germany. · Laura and Isaac Perlmutter Cancer Center Professor of Medicine NYU, New-York, USA. · University of California, San Francisco, San Francisco, CA, USA. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · University of Zurich, Zurich, Switzerland. · Karolinska University Hospital Solna, Stockholm Sweden. · Medical University of Vienna, Austria. · The Ella Lemelbaum Institute for Immuno-Oncology Division of Oncology Sheba Medical Center Tel Hashomer, Israel. · Netherlands Cancer Institute, The Netherlands. · University Hospital Tuebingen, Germany. · Pubmed 29224903
2017
  • The Ella Lemelbaum Institute of Immuno-oncology, Institute of Oncology, Sheba Medical Center, Tel Hashomer, Israel. · Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Talpiot Medical Leadership Program, Sheba Medical Center, Tel Hashomer, Israel. · Pubmed 28543698
  • The Angeles Clinic and Research Institute, Los Angeles, CA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Zürich, Zürich, Switzerland. · Ella Lemelbaum Institute of Melanoma, Sheba Medical Center, Tel Hashomer, Israel. · University of California, San Francisco, San Francisco, CA, USA. · University Hospital Essen, Essen, Germany. · Netherlands Cancer Institute, Amsterdam, The Netherlands. · University of Arizona Cancer Center, Tucson, AZ, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · New York University Cancer Institute, New York, NY, USA. · University of Colorado Denver, Aurora, CO, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · Duke Cancer Institute, Durham, NC, USA. · City of Hope, Duarte, CA, USA. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · Merck & Co., Inc., Kenilworth, NJ, USA. · University of California Los Angeles, Los Angeles, CA, USA. · Pubmed 28961465
  • From the Melanoma Institute Australia, University of Sydney, Royal North Shore and Mater Hospitals (G.V.L.), and Macquarie University, Melanoma Institute Australia, University of Sydney, and Westmead Hospital (R.K.), Sydney, Princess Alexandra Hospital, Gallipoli Medical Research Foundation, University of Queensland, Brisbane (V.A.), and Alfred Hospital, Melbourne, VIC (A. Haydon) - all in Australia · University Hospital Schleswig-Holstein, Kiel (A. Hauschild), and University Hospital Essen, Essen, and the German Cancer Consortium, Heidelberg (D.S.) - all in Germany · Fondazione Istituto Nazionale Tumori, Milan (M.S.), Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M.M.), and the Melanoma Oncology Unit, Veneto Oncology Institute, Padua (V.C.-S.) - all in Italy · Rikshospitalet-Radiumhospitalet, Oslo (M.N.) · Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux (C.D.), Institute Gustave Roussy, Paris (C.R.), Université de Lille, INSERM Unité 1189, Centre Hospitalier Régional Universitaire de Lille, Lille (L.M.), and the Medical Oncology Department, Centre Eugène Marquis, Rennes (T.L.) - all in France · Ella Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel (J.S.) · Royal Marsden NHS Foundation Trust, London (J. Larkin), and Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne (R.P.) - both in the United Kingdom · Novartis Pharmaceuticals, East Hanover, NJ (R.J., P.Z., B.M., J. Legos) · University Hospital Zürich Skin Cancer Center, Zurich, Switzerland (R.D.) · and the Melanoma Program, Hillman UPMC Cancer Center, University of Pittsburgh, Pittsburgh (J.M.K.). · Pubmed 28891408
  • Division of Oncology, Ella Lemelbaum Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel. Electronic address: · Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Department of Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney, Mater Hospital and Royal North Shore Hospital, Sydney, Australia. · Department of Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain. · Department of Dermatology and Skin Cancer, Aix Marseille University, Hôpital de la Timone, Marseille, France. · Department of Dermatology, Université Lille, INSERM U1189, CHU Lille, F-59000, France. · Department of Hematology/Oncology, University of California, San Francisco, San Francisco, CA, USA. · Department of Medical Oncology, Westmead and Blacktown Hospitals, Melanoma Institute Australia, and The University of Sydney, Sydney, Australia. · Department of Medical Oncology, Chris O'Brien Lifehouse, Royal Prince Alfred Hospital, and Melanoma Institute Australia, Camperdown, Australia. · Department of Melanoma and Cancer Immunotherapy, Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel. · Department of Medical Oncology, Royal Marsden Hospital, London, UK. · Department of Medical Oncology University of Manchester and the Christie NHS Foundation Trust, Manchester, UK. · Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Medicine, Division of Medical Oncology/Hematology, Sunnybrook Health Sciences Center, Toronto, ON, Canada. · Department of Hematology/Oncology, The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Department of BARDS, Merck & Co, Kenilworth, NJ, USA. · Department of Clinical Oncology, Merck & Co, Kenilworth, NJ, USA. · Department of Oncology, Gustave Roussy and Paris-Sud University, Villejuif, France. · Pubmed 28822576
  • Department of Surgery C, Chaim Sheba Medical Center, Ramat Gan, Israel. · Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel. · Department of Surgery, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Pubmed 28650570
  • Department of Dermatology, University Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany; German Cancer Consortium, 69117 Heidelberg, Germany. Electronic address: · Melanoma Institute Australia, The University of Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, NSW, Australia. · Moscow City Oncology Hospital No 62, Moscow 143423, Russia. · Przychodnia Lekarska KOMED, Wojska Polskiego 6, 62-500 Konin, Poland. · Department of Dermatology, University Medical Center Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany. · Petrov Research Institute of Oncology, 68 Leningradskaya Street, Saint Petersburg 197758, Russia. · Melanoma and Esophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Via Gattamelata 64, 35128 Padova, Italy. · Oncology Division, Sheba Medical Center, Tel HaShomer, Emek HaEla St 1, Ramat Gan, Israel. · Department of Dermatology, University of Tübingen, Geschwister-Scholl-Platz, 72074 Tübingen, Germany. · Service de Dermatologie et Dermatologie Pédiatrique, Hôpital Saint-André, 1 Rue Jean Burguet, 33000 Bordeaux, France. · First Department of Medicine, "Laiko" General Hospital, National and Kapodistrian University of Athens, Athens 157 72, Greece. · Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Paris, France. · Department of Cancer Immunology, Poznan University of Medical Sciences, 15 Garbary Street, 61-866 Poznań, Poland. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Wawelska 15B, 02-034 Warsaw, Poland. · Department of Dermatology, University Hospital Center, Timone Hospital, Aix Marseille University, 264 Rue St Pierre, 13885 Marseille Cedex 05, France. · Mount Vernon Cancer Centre, Rickmansworth Road, HA6 2RN Northwood, UK. · Department of Medicine, Hematology/Oncology, UCLA Medical Center, 100 UCLA Medical Plaza, Suite 550, Los Angeles, CA, USA. · Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston 77030, TX, USA. · Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover 07936, NJ, USA. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston 02114, MA, USA. · Department of Medical Oncology, Dermatology Service, Gustave Roussy Comprehensive Cancer Center and Faculty of Medicine, University Paris-South, F-94805, Villejuif, France. · Pubmed 28648698
  • The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, The Netherlands. Electronic address: · The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Department of Medical Oncology, Hospital Clínic Barcelona, Barcelona, Spain. Electronic address: · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany. Electronic address: · IRCCS San Martino-IST, Genova, Italy. Electronic address: · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Electronic address: · General University Hospital, Dermatooncology U, Prague, Czech Republic. Electronic address: · Chaim Sheba Medical Centre, Oncology Institute, Ramat-Gan, Israel. Electronic address: · Afdelingshoofd, Medische Oncologie, Brussels, Belgium. Electronic address: · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. Electronic address: · Oncology Institute of Veneto-IRCCS, Padova, Italy. Electronic address: · Papa Giovanni XIII Hospital, Bergamo, Italy. Electronic address: · University of Athens, Athens, Greece. Electronic address: · Hospital La Paz, Madrid, Spain. Electronic address: · University Medical Centre Groningen, Groningen, The Netherlands. Electronic address: · McGill University, Segal Cancer Centre, Montreal, Quebec, Canada. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia; Discipline of Medicine, University of Adelaide, Adelaide, Australia. Electronic address: · Pubmed 28501764
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne and University of Melbourne, Parkville, Australia. · AOU Senese Policlinico Santa Maria Alle Scotte, Siena, Italy. · Department of Medical Oncology, Hospital Clínic Barcelona, Spain. · Mount Vernon Hospital, Centre for Cancer Treatment, Northwood, UK. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · University Paris Descartes, Hospital Cochin, APHP, Paris, France. · Department of Dermatology, University Hospital Tuebingen, Tuebingen. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel. · Department of Dermatology, Comprehensive Cancer Center, University Hospital Essen, Essen, Germany. · Angeles Clinic and Research Institute, Los Angeles, USA. · Fachklinik Hornheide, Munster, Germany. · Moffitt Cancer Center, Tampa, USA. · Chaim Sheba Medical Centre, Oncology Institute, Ramat-Gan, Israel. · Crown Princess Cancer Centre Westmead Hospital and Department of Clinical Medicine, Macquarie University, Sydney NSW, Australia. · Seattle Cancer Care Alliance, Seattle, USA. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · University of Colorado Cancer Center, Aurora. · City of Hope, Duarte, USA. · Pubmed 27993793
  • Mario Sznol, Yale Comprehensive Cancer Center, New Haven, CT · Pier Francesco Ferrucci, Istituto Europeo di Oncologia, Milan · Massimo Guidoboni, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy · David Hogg, Princess Margaret Cancer Centre, Toronto, Ontario, Canada · Michael B. Atkins, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC · Pascal Wolter, University Hospitals Leuven, Leuven, Belgium · Celeste Lebbé, Université Paris Diderot, Paris · Luc Thomas, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France · John M. Kirkwood, Hillman Cancer Center, Pittsburgh, PA · Jacob Schachter, Sheba Medical Center, Ramat Gan, Israel · Gregory A. Daniels, University of California San Diego, Moores Cancer Center, La Jolla, CA · Jessica Hassel, University Hospital, Heidelberg, Germany · Jonathan Cebon, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria · Winald Gerritsen, University of Queensland, St Lucia · Victoria Atkinson, Gallipoli Medical Research Foundation, Greenslopes · Victoria Atkinson, Princess Alexandra Hospital, Brisbane, Queensland, Australia · Winald Gerritsen, Radboud University Medical Center, Nijmegen, the Netherlands · John McCaffrey, Irish Clinical Oncology Research Group, Dublin · Derek Power, Irish Clinical Oncology Research Group, Cork, Ireland · Dana Walker, Rafia Bhore, and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · and Jedd D. Wolchok, Parker Institute and Ludwig Center at Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 28915085
2016
  • The Ella Lemelbaum Institute for Melanoma, Sheba Medical Center, 52621 Ramat-Gan, Israel. · Department of Clinical Microbiology & Immunology, Sackler School of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel. · Pubmed 26653685
  • University Hospital Essen, Hufelandstrasse 55, D-45147 Essen, Germany. Electronic address: · Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091 Zurich, Switzerland. Electronic address: · Department of Dermatology, Venereology, and Allergology, University Hospital Schleswig-Holstein, Kiel Campus, Arnold-Heller Strasse 3, 24105 Kiel, Germany. Electronic address: · Gustave Roussy Cancer Campus and Paris-Sud University, 114 Rue Edouard Vaillant, 94800 Villejuif, France. Electronic address: · The Angeles Clinic and Research Institute, 2001 Santa Monica Blvd, Ste 560W, Santa Monica, CA 90404, USA. Electronic address: · University of California, San Francisco School of Medicine, 1600 Divisadero St, NZ Bldg A, San Francisco, CA 94115, USA. Electronic address: · Department of Medical Oncology, VU University Medical Center Amsterdam, De Boelelaan 1118, 1081 HZ Amsterdam, The Netherlands. Electronic address: · Department of Hematology/Oncology, University of Arizona Cancer Center at UMC North, 3838 N. Campbell Ave, Tucson, AZ 85724, USA. Electronic address: · The Los Angeles Skin Cancer Institute, The Beverly Hills Cancer Center, 8900 Wilshire Blvd, Beverly Hills, CA 90211, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, 2220 Pierce Ave, 777 Preston Research Building, Nashville, TN 37232, USA. Electronic address: · Department of Oncology, Ella Institute for Melanoma, Sheba Medical Center, Derech Sheba 2, Tel-Hashomer, Ramat-Gan, Israel. Electronic address: · Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Division of Medical Oncology, Duke Cancer Institute, Duke University Medical Center, Box 3198, 20 Duke Medicine Circle, Durham, NC 27710, USA. Electronic address: · Skin Clinic, Universitätsmedizin Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany. Electronic address: · Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08901, USA. Electronic address: · Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: · Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: · Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: · Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: · Department of Medicine, Division of Hematology-Oncology, Jonsson Comprehensive Cancer Center (JCCC) at the University of California, Los Angeles (UCLA), 10833 Le Conte Ave, Los Angeles, CA 90095, USA. Electronic address: · Pubmed 27596353
  • Ella Lemelbaum Institute of Melanoma, Sheba Medical Center, Ramat Gan, Israel. · Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Israel. · Talpiot Medical Leadership program, Sheba Medical Center, Ramat Gan, Israel. · Pubmed 26885752
2015
  • Ella Lemelbaum Institute for Melanoma, Division of Oncology, Sheba Medical Center, Tel Hashomer, Israel. · Pubmed 26065473
  • Service de Dermatologie, Aix Marseille University, and Assistance Publique Hôpitaux de Marseille (APHM), University Hospital Timone, Marseille, France. Electronic address: · GlaxoSmithKline Oncology Research and Development, Collegeville, PA, USA. · Przychodnia Lekarska Komed, Konin, Poland. · Sheba Medical Center, Ramat Gan, Ramat, Israel. · Department of Dermatology, Universität Zürich, Zurich, Switzerland. · Oncology Division, Poznan University of Medical Sciences, Med-Polonia, Poznan, Poland. · Moscow City Oncology Hospital #62, Stepanovskoye, Moscow, Russia. · Swissmed Centrum Zdrowia and Gdansk Medical University, Gdansk, Poland. · Centre Hospitalier Universitairede Reims-Hôpital Robert Debré, Reims, France. · Istituto Oncologico Veneto Istituto Di Ricovero e Cura a Carattere Scientifico, Padua, Italy. · Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. · N N Blokhin Russian Cancer Research Center, Moscow, Russia. · Petrov Research Institute of Oncology, Saint Petersburg, Russia. · University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. · Universitätsklinikum Schleswig-Holstein (UKSH), Department of Dermatology, Kiel, Germany. · Melanoma Institute Australia, The University of Sydney and The Mater Hospital, Sydney, Australia. · Mount Vernon Cancer Centre, Northwood, UK. · University of California Los Angeles (UCLA) Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Department of Dermatology, University Hospital Essen, Essen, Germany. · Gustave Roussy, Département de Médecine oncologique, Service de Dermatologie et Université Paris-Sud, Faculté de Médecine, Villejuif, France. · Pubmed 26433819
  • University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Zürich, Zürich, Switzerland. · University Hospital Essen, Essen, Germany. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Dana-Farber Cancer Institute, Boston, MA, USA. · Sheba Medical Center, Tel Hashomer, Israel. · New York University Cancer Institute, New York, NY, USA. · University of Colorado Denver, Aurora, CO, USA. · University of Arizona Cancer Center, Tucson, AZ, USA. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · Duke Cancer Institute, Durham, NC, USA. · Seattle Cancer Care Alliance/University of Washington, Seattle, WA, USA. · University Medical Center, Mainz, Germany. · Universitätsklinikum Tübingen, Tübingen, Germany. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, and Melanoma Institute Australia, Westmead, NSW, Australia. · St Luke's Cancer Center, Bethlehem, PA, USA; Temple University, Philadelphia, PA, USA. · University of North Carolina, Chapel Hill, NC, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Merck & Co, Kenilworth, NJ, USA. · University of California, San Francisco, San Francisco, CA, USA. · Pubmed 26115796
  • The Ella Lemelbaum Institute for Melanoma, Sheba Medical Center, 52621 Tel Hashomer, Israel. · The Ella Lemelbaum Institute for Melanoma, Sheba Medical Center, 52621 Tel Hashomer, Israel ; Talpiot Medical Leadership Program, Sheba Medical Center, 52621 Tel Hashomer, Israel. · The Ella Lemelbaum Institute for Melanoma, Sheba Medical Center, 52621 Tel Hashomer, Israel ; Talpiot Medical Leadership Program, Sheba Medical Center, 52621 Tel Hashomer, Israel ; Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, 69102 Tel Aviv, Israel. · Pubmed 26688824
  • Ella Institute of Melanoma Research, Sheba Medical Center, Ramat-Gan, Israel. · Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Talpiot Medical Leadership Program, Sheba Medical Center, Ramat-Gan, Israel. · Pubmed 26158900
  • Department of Surgery C, Chaim Sheba Medical Center, Tel Hashomer, Israel. · Ella Institute of Melanoma, Chaim Sheba Medical Center, Tel Hashomer, Israel. · Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 25573088
2014
  • Royal Marsden Hospital NHS Foundation Trust, London, UK. Electronic address: · Department of Medical Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Dermatooncology Department, General University Hospital, Prague, Czech Republic. · Ella Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel. · Universitair Ziekenhuis Brussel, Brussels, Belgium. · Service of Oncology-Hospital La Paz, Madrid, Spain. · Universität Tübingen-Hautklinik, Tübingen, Germany. · Melanoma Oncology Unit, Veneto Oncology Institute, Gattamelata, Padova, Italy. · Medical Oncology, University of Athens, Greece. · Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC, Canada. · Papa Giovanni XXIII Hospital, Bergamo, Italy. · Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands. · Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. · IRCCS San Martino Hospital-IST, Genoa, Italy. · University Hospital Schleswig-Holstein, Department of Dermatology, Kiel, Germany. · Cancer Clinical Trials Unit, Royal Adelaide Hospital, and Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia. · F Hoffmann-La Roche, Basel, Switzerland. · Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. Electronic address: · Pubmed 24582505
  • Ella Institute of Melanoma, Sheba Medical Center, Ramat-Gan, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Ella Institute of Melanoma, Sheba Medical Center, Ramat-Gan, Israel. · Institute of Pathology, Sheba Medical Center, Ramat-Gan 526260, Israel. · Cancer Research Center, Sheba Medical Center, Ramat-Gan, Israel. · Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Dermatology, Sheba Medical Center, Ramat-Gan, Israel. · The Susanne-Levy Gertner Oncogenetics Unit, Danek Gertner Institute of Human Genetics, Ramat-Gan, Israel. · Ella Institute of Melanoma, Sheba Medical Center, Ramat-Gan, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Talpiot Medical Leadership Program, Sheba Medical Center, Ramat-Gan, Israel. Electronic address: · Pubmed 24931667
  • Sheba Medical Center, Ella Institute of Melanoma, Ramat Gan, Israel Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Sheba Medical Center, Ella Institute of Melanoma, Ramat Gan, Israel. · Cancer Research Center, Ramat Gan, Israel. · Sheba Medical Center, Ella Institute of Melanoma, Ramat Gan, Israel Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel Talpiot Medical Leadership Program, Sheba Medical Center, Ramat Gan, Israel · Pubmed 24920276
2017
  • From the *Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel Hashomer; and †Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 28114254
2016
  • Departments of *Thoracic Surgery †Ella Lemelbaum Institute of Melanoma ‡General and Bariatric Surgery, Sheba Medical Center, Tel Hashomer §Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 27163742
2015
  • 1First Department of Medicine, Athens University Medical School, Athens, Greece; 2Division of Medical Oncology, Baskent University School of Medicine, Adana, Turkey; 3Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale," Naples, Italy; 4Department of Biotherapy, Blokhin Cancer Center, Moscow, Russia; 5Department of Dermatology, Medical University of Vienna, Vienna, Austria; 6Department of Dermatology, Institute Gustave Roussy, Villejuif Cedex, France; 7Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel; 8Department of Dermatologie, University of Kiel, Kiel, Germany; and 9Oncology Service, Hospital La Paz, Madrid, Spain. · Pubmed 24176884
2014
  • Department of Diagnostic Imaging, Sheba Medical Center, Tel-Hashomer, 2 Sheba Rd, Tel Hashomer 52621, Israel, affiliated to Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel, · Pubmed 24663820
2013
  • Ella Institute for Melanoma, Sheba Medical Center, 52621 Ramat-Gan, Israel. · Pubmed 23516145
  • Ella Institute for Melanoma, Sheba Medical Center, 52621 Ramat Gan, Israel. · Pubmed 23256800
  • Ella Institute of Melanoma, Department of Surgical Oncology, Sheba Medical Center, Ramat Gan, Israel. · Pubmed 23690483
  • Ella Institute of Melanoma, Sheba Medical Center , Ramat-Gan , Israel . · Pubmed 23902289
  • Ella Institute of Melanoma, Sheba Medical Center, Tel Hashomer, Israel. · Pubmed 23483943
  • Ella Institute of Melanoma, Sheba Medical Center, Ramat-Gan, Israel. · Pubmed 23451174
2012
  • Ella Institute for the Treatment and Research of Melanoma, Sheba Medical Center, Ramat-Gan, 52621, Israel. · Pubmed 22864561
  • Ella Institute for Melanoma, Sheba Medical Center, Ramat Gan 52621, Israel. · Pubmed 22778766
  • Department of Neurobiology, George S. Wise Faculty of Life Sciences, Tel Aviv University, 69978 Tel Aviv, Israel. · Pubmed 23028055
  • Ella Institute of Melanoma, Sheba Medical Center, Ramat-Gan, Israel. · Pubmed 22466331
  • The Ella Institute for Melanoma Research and Treatment, Cancer Research Center, Sheba Medical Center, 52621 Ramat Gan, Tel Hashomer, Israel. · Pubmed 22441657
2011
  • Ella Institute of Melanoma, Sheba Medical Center, Tel Hashomer, Israel. · Pubmed 21541354
  • Ella Institute for Treatment and Research of Melanoma, Sheba Medical Center, Tel-Hashomer, Israel. · Pubmed 21304398
2010
  • Ella Institute of Melanoma, Sheba Medical Center, Tel-Hashomer 52621, Israel. · Pubmed 21234353
  • Ella Institute of Melanoma, Sheba Medical Center, Tel-Hashomer, Israel. · Pubmed 20406835
  • The Ella Institute for Melanoma Research and Treatment, Sheba Cancer Research Center, Sheba Medical Center, 52621 Tel Hashomer, Israel. · Pubmed 19633846
2009
  • The Ella Institute for Treatment and Research of Melanoma, Sheba Medical Center, Tel-Hashomer, Israel. · Pubmed 19342963
  • Department of Surgery C & Surgical Oncology, Sheba Medical Center, Tel Hashomer, Israel. · Pubmed 20108553
  • Division of Oncology, Chaim Sheba Medical Center, Tel-Hashomer, Israel. · Pubmed 19455066
  • Department of Dermatology, Tel Aviv-Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 19443406
  • Ella Institute of Melanoma, Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel. · Pubmed 19440333
  • Ella Institute of Melanoma, Sheba Medical Center, Tel-Hashomer, Israel. · Pubmed 19148842
Probable:    Tel Aviv Sourasky Medical Center      
2018
  • Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel. Electronic address: · Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Israel. · Division of Oncology, Sheba Medical Center, Ramat-Gan, Israel. · Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel. · Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel; Department of Oncology, Sackler Faculty of Medicine, Tel Aviv University, Israel. · Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Israel; Talpiot Medical Leadership Program, Sheba Medical Center, Ramat-Gan, Israel. · Pubmed 30096703
2017
  • The Ella Lemelbaum Institute of Immuno-oncology, Institute of Oncology, Sheba Medical Center, Tel Hashomer, Israel. · Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Talpiot Medical Leadership Program, Sheba Medical Center, Tel Hashomer, Israel. · Pubmed 28543698
  • Department of Surgery C, Chaim Sheba Medical Center, Ramat Gan, Israel. · Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel. · Department of Surgery, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Pubmed 28650570
2015
  • Department of Surgery C, Chaim Sheba Medical Center, Tel Hashomer, Israel. · Ella Institute of Melanoma, Chaim Sheba Medical Center, Tel Hashomer, Israel. · Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 25573088
2017
  • From the *Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel Hashomer; and †Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 28114254
2016
  • Departments of *Thoracic Surgery †Ella Lemelbaum Institute of Melanoma ‡General and Bariatric Surgery, Sheba Medical Center, Tel Hashomer §Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 27163742
2014
  • Department of Diagnostic Imaging, Sheba Medical Center, Tel-Hashomer, 2 Sheba Rd, Tel Hashomer 52621, Israel, affiliated to Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel, · Pubmed 24663820
2009
  • Department of Dermatology, Tel Aviv-Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 19443406
Probable:    Miscellaneous institutions in Tel Aviv      
2018
  • Ella Lemelbaum Institute for Immuno-Oncology, Ramat-Gan, 52621, Israel. · Sackler Faculty of Medicine, Department of Clinical Microbiology and Immunology, Tel Aviv, 69978, Israel. · Department of Cancer Biology, MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Pathology, Sheba Medical Center, Ramat Gan, 52621, Israel. · Ella Lemelbaum Institute for Immuno-Oncology, Ramat-Gan, 52621, Israel. · Sackler Faculty of Medicine, Department of Clinical Microbiology and Immunology, Tel Aviv, 69978, Israel. · Talpiot Medical Leadership Program, Sheba Medical Center, Ramat-Gan, 52621, Israel. · Pubmed 29855470
2013
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 65 total) written by Jacob Schachter about Melanoma:

  • Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma. 2019
  • Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma. 2019
  • Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006. 2018
  • Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT). 2018
  • Possible immune adverse events as predictors of durable response to BRAF inhibitors in patients with BRAF V600-mutant metastatic melanoma. 2018
  • ADAR1-mediated regulation of melanoma invasion. 2018
  • Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma Cells. 2018
  • Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III. 2018
  • Adoptive T cell therapy: An overview of obstacles and opportunities. 2017
  • Adoptive Cell Therapy for Metastatic Melanoma. 2017
Show List of Full Article Records
Google Searches

Learn more about Jacob Schachter using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Tel Aviv University
Tel Aviv Sourasky Medical Center
Miscellaneous institutions in Tel Aviv
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Tel Aviv University
2019
  • Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples, Italy. · European Institute of Oncology IRCCS, Milan, Italy. · Auckland City Hospital, Auckland, New Zealand. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Brisbane, Queensland, Australia. · Aarhus University Hospital, Aarhus, Denmark. · Ella Lemelbaum Institute for Melanoma, Sheba Medical Center at Tel HaShomer, Cancer Center (Oncology Institute), Ramat Gan, Israel. · IRCCS San Martino-IST, Genova, Italy. · Melanoma Institute Australia and the University of Sydney, Mater and Royal North Shore Hospitals, Sydney, New South Wales, Australia. · Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. · Herlev Hospital, University of Copenhagen, Herlev, Denmark. · Sharett Institute of Oncology, Hadassah Hebrew Medical Center, Jerusalem, Israel. · Rambam Health Care Campus, Haifa, Israel. · Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec, Québec, Canada. · Novartis, East Hanover, NJ, USA. · Merck & Co., Inc., Kenilworth, NJ, USA. · University of California Los Angeles and the Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Pubmed 31171878
  • From Institut Gustave Roussy and Paris-Sud-Paris-Saclay University, Villejuif (C.R.), Aix-Marseille University, Marseille (J.J.G.), and Assistance Publique-Hôpitaux de Paris Dermatology and Clinical Investigation Center, Unité 976, Université de Paris, Hôpital Saint-Louis, Paris (C.L.) - all in France · Moscow City Oncology Hospital, Moscow (D. Stroyakovskiy), and the Petrov Research Institute of Oncology, St. Petersburg (E.L.) - both in Russia · Przychodnia Lekarska Komed, Konin (B.K.), the University of Medical Sciences, Poznań (A.M.), and the Maria Skłodowska-Curie Institute-Oncology Center, Warsaw (P.R.) - all in Poland · the University Hospital Schleswig-Holstein, Kiel (A.H.), the Department of Dermatology, University of Tübingen, Tübingen (C.G.), University Hospital Essen, Essen (D. Schadendorf), and the German Cancer Consortium, Heidelberg (D. Schadendorf) - all in Germany · the Veneto Institute of Oncology, Padua (V.C.S.), and Papa Giovanni XXIII Hospital, Bergamo (M.M.) - both in Italy · the Ella Lemelbaum Institute for Immuno-Oncology and Melanoma, Sheba Medical Center, Tel Hashomer (J.S.), and Sackler Medical School, Tel Aviv University, Tel Aviv (J.S.) - both in Israel · Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine (I.B.) · Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens (H.G.) · the Netherlands Cancer Institute, Amsterdam (J.B.A.G.H.) · Mount Vernon Cancer Centre, Northwood, United Kingdom (P.D.N.) · the University of California, Los Angeles, Los Angeles (A.R.) · the University of Texas M.D. Anderson Cancer Center, Houston (M.A.D.) · Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston (K.T.F.) · Novartis Pharma, Basel, Switzerland (P.B.) · Novartis Pharmaceuticals, East Hanover, NJ (M.T., E.G., M.V.) · and the Melanoma Institute Australia, the University of Sydney, and Royal North Shore and Mater Hospitals, Sydney (G.V.L.). · Pubmed 31166680
2018
  • The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · University of California, Los Angeles, Los Angeles, CA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Princess Alexandra Hospital, Brisbane, Australia. · University of California, San Francisco, San Francisco, CA, USA. · Hospital Clinic de Barcelona, Barcelona, Spain. · Edinburgh Cancer Research Centre and Western General Hospital, Edinburgh, Scotland, UK. · Medical University of Vienna, Vienna, Austria. · Centre Hospitalier Régional Universitaire de Lille, Université Lille, Lille, France. · Ella Lemelbaum Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel. · Merck & Co., Inc, Kenilworth, NJ, USA. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · Pubmed 30202085
  • Richard D. Carvajal and Gary K. Schwartz, Columbia University Medical Center · Paul B. Chapman and Alexander N. Shoushtari, Memorial Sloan Kettering Cancer Center, New York, NY · Sophie Piperno-Neumann and Manuel J. Rodrigues, Institut Curie, Paris · Lauris Gastaud, Centre Antoine-Lacassagne, Nice, France · Ellen Kapiteijn, Leiden University Medical Center, Leiden, the Netherlands · Stephen Frank, Hebrew University Hadassah Medical School - The Sharett Institute of Oncology, Jerusalem · Jacob Schachter, Sheba Medical Center at Tel Hashomer, and Tel-Aviv University Medical School, Tel Aviv, Israel · Anthony M. Joshua, Princess Margaret Cancer Centre, Toronto, ON, Canada · Josep M. Piulats, Institut Catala d'Oncologia L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain · Pascal Wolter, University Hospitals Leuven, Leuven, Belgium · Veronique Cocquyt, Ghent University Hospital, Ghent, Belgium · Bartosz Chmielowski, University of California, Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, CA · T.R. Jeffry Evans, University of Glasgow, Glasgow · Delyth Clemett, Shirley Spratt, Susan Lovick, and Elaine Kilgour, AstraZeneca, Macclesfield · Dana Ghiorghiu and Gabriella Mariani, AstraZeneca, Cambridge · Paul Nathan, Mt Vernon Cancer Centre, Northwood, United Kingdom · Gerald Linette, Washington University School of Medicine, St Louis, MO · Carola Berking, University Hospital of Munich, Munich, Germany · Peter Barker, AstraZeneca, Gaithersburg, MD · and Zhongwu Lai, AstraZeneca, Waltham, MA. · Pubmed 29528792
  • Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel. Electronic address: · Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Israel. · Division of Oncology, Sheba Medical Center, Ramat-Gan, Israel. · Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel. · Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel; Department of Oncology, Sackler Faculty of Medicine, Tel Aviv University, Israel. · Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Israel; Talpiot Medical Leadership Program, Sheba Medical Center, Ramat-Gan, Israel. · Pubmed 30096703
  • Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Ramat-Gan, 5262620, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Ramat-Gan, 5262620, Israel. · Institute of Pathology, Sheba Medical Center, Ramat-Gan, 5262620, Israel; Talpiot Medical Leadership Program, Sheba Medical Center, Ramat-Gan, 5262620, Israel. · Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Ramat-Gan, 5262620, Israel; Talpiot Medical Leadership Program, Sheba Medical Center, Ramat-Gan, 5262620, Israel. · Ella Lemelbaum Institute of Immuno-Oncology, Sheba Medical Center, Ramat-Gan, 5262620, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; School of Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: · Pubmed 29558679
  • Aix Marseille University and APHM University-Hospital Marseille France, France. Electronic address: · University of Essen and German Cancer Consortium, Heidelberg, Germany. · University of Manchester, Christie National Foundation Trust Manchester, UK. · Istituto Nazionale Tumori - Fondazione "G. Pascale", Napoli, Italy. · Royal Marsden Hospital, London, UK. · Mount Vernon Cancer Centre, UK. · Gustave Roussy and Paris-Sud University, Paris, France. · Universitätsklinikum Schleswig-Holstein, Kiel, Germany. · Laura and Isaac Perlmutter Cancer Center Professor of Medicine NYU, New-York, USA. · University of California, San Francisco, San Francisco, CA, USA. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · University of Zurich, Zurich, Switzerland. · Karolinska University Hospital Solna, Stockholm Sweden. · Medical University of Vienna, Austria. · The Ella Lemelbaum Institute for Immuno-Oncology Division of Oncology Sheba Medical Center Tel Hashomer, Israel. · Netherlands Cancer Institute, The Netherlands. · University Hospital Tuebingen, Germany. · Pubmed 29224903
2017
  • The Ella Lemelbaum Institute of Immuno-oncology, Institute of Oncology, Sheba Medical Center, Tel Hashomer, Israel. · Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Talpiot Medical Leadership Program, Sheba Medical Center, Tel Hashomer, Israel. · Pubmed 28543698
  • The Angeles Clinic and Research Institute, Los Angeles, CA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Zürich, Zürich, Switzerland. · Ella Lemelbaum Institute of Melanoma, Sheba Medical Center, Tel Hashomer, Israel. · University of California, San Francisco, San Francisco, CA, USA. · University Hospital Essen, Essen, Germany. · Netherlands Cancer Institute, Amsterdam, The Netherlands. · University of Arizona Cancer Center, Tucson, AZ, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · New York University Cancer Institute, New York, NY, USA. · University of Colorado Denver, Aurora, CO, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · Duke Cancer Institute, Durham, NC, USA. · City of Hope, Duarte, CA, USA. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · Merck & Co., Inc., Kenilworth, NJ, USA. · University of California Los Angeles, Los Angeles, CA, USA. · Pubmed 28961465
  • From the Melanoma Institute Australia, University of Sydney, Royal North Shore and Mater Hospitals (G.V.L.), and Macquarie University, Melanoma Institute Australia, University of Sydney, and Westmead Hospital (R.K.), Sydney, Princess Alexandra Hospital, Gallipoli Medical Research Foundation, University of Queensland, Brisbane (V.A.), and Alfred Hospital, Melbourne, VIC (A. Haydon) - all in Australia · University Hospital Schleswig-Holstein, Kiel (A. Hauschild), and University Hospital Essen, Essen, and the German Cancer Consortium, Heidelberg (D.S.) - all in Germany · Fondazione Istituto Nazionale Tumori, Milan (M.S.), Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M.M.), and the Melanoma Oncology Unit, Veneto Oncology Institute, Padua (V.C.-S.) - all in Italy · Rikshospitalet-Radiumhospitalet, Oslo (M.N.) · Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux (C.D.), Institute Gustave Roussy, Paris (C.R.), Université de Lille, INSERM Unité 1189, Centre Hospitalier Régional Universitaire de Lille, Lille (L.M.), and the Medical Oncology Department, Centre Eugène Marquis, Rennes (T.L.) - all in France · Ella Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel (J.S.) · Royal Marsden NHS Foundation Trust, London (J. Larkin), and Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne (R.P.) - both in the United Kingdom · Novartis Pharmaceuticals, East Hanover, NJ (R.J., P.Z., B.M., J. Legos) · University Hospital Zürich Skin Cancer Center, Zurich, Switzerland (R.D.) · and the Melanoma Program, Hillman UPMC Cancer Center, University of Pittsburgh, Pittsburgh (J.M.K.). · Pubmed 28891408
  • Division of Oncology, Ella Lemelbaum Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel. Electronic address: · Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Department of Medical Oncology and Translational Research, Melanoma Institute Australia, The University of Sydney, Mater Hospital and Royal North Shore Hospital, Sydney, Australia. · Department of Medical Oncology, Hospital Clinic de Barcelona, Barcelona, Spain. · Department of Dermatology and Skin Cancer, Aix Marseille University, Hôpital de la Timone, Marseille, France. · Department of Dermatology, Université Lille, INSERM U1189, CHU Lille, F-59000, France. · Department of Hematology/Oncology, University of California, San Francisco, San Francisco, CA, USA. · Department of Medical Oncology, Westmead and Blacktown Hospitals, Melanoma Institute Australia, and The University of Sydney, Sydney, Australia. · Department of Medical Oncology, Chris O'Brien Lifehouse, Royal Prince Alfred Hospital, and Melanoma Institute Australia, Camperdown, Australia. · Department of Melanoma and Cancer Immunotherapy, Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel. · Department of Medical Oncology, Royal Marsden Hospital, London, UK. · Department of Medical Oncology University of Manchester and the Christie NHS Foundation Trust, Manchester, UK. · Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Medicine, Division of Medical Oncology/Hematology, Sunnybrook Health Sciences Center, Toronto, ON, Canada. · Department of Hematology/Oncology, The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Department of BARDS, Merck & Co, Kenilworth, NJ, USA. · Department of Clinical Oncology, Merck & Co, Kenilworth, NJ, USA. · Department of Oncology, Gustave Roussy and Paris-Sud University, Villejuif, France. · Pubmed 28822576
  • Department of Surgery C, Chaim Sheba Medical Center, Ramat Gan, Israel. · Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel. · Department of Surgery, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Pubmed 28650570
  • Department of Dermatology, University Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany; German Cancer Consortium, 69117 Heidelberg, Germany. Electronic address: · Melanoma Institute Australia, The University of Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, NSW, Australia. · Moscow City Oncology Hospital No 62, Moscow 143423, Russia. · Przychodnia Lekarska KOMED, Wojska Polskiego 6, 62-500 Konin, Poland. · Department of Dermatology, University Medical Center Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany. · Petrov Research Institute of Oncology, 68 Leningradskaya Street, Saint Petersburg 197758, Russia. · Melanoma and Esophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Via Gattamelata 64, 35128 Padova, Italy. · Oncology Division, Sheba Medical Center, Tel HaShomer, Emek HaEla St 1, Ramat Gan, Israel. · Department of Dermatology, University of Tübingen, Geschwister-Scholl-Platz, 72074 Tübingen, Germany. · Service de Dermatologie et Dermatologie Pédiatrique, Hôpital Saint-André, 1 Rue Jean Burguet, 33000 Bordeaux, France. · First Department of Medicine, "Laiko" General Hospital, National and Kapodistrian University of Athens, Athens 157 72, Greece. · Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Paris, France. · Department of Cancer Immunology, Poznan University of Medical Sciences, 15 Garbary Street, 61-866 Poznań, Poland. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Wawelska 15B, 02-034 Warsaw, Poland. · Department of Dermatology, University Hospital Center, Timone Hospital, Aix Marseille University, 264 Rue St Pierre, 13885 Marseille Cedex 05, France. · Mount Vernon Cancer Centre, Rickmansworth Road, HA6 2RN Northwood, UK. · Department of Medicine, Hematology/Oncology, UCLA Medical Center, 100 UCLA Medical Plaza, Suite 550, Los Angeles, CA, USA. · Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston 77030, TX, USA. · Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover 07936, NJ, USA. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston 02114, MA, USA. · Department of Medical Oncology, Dermatology Service, Gustave Roussy Comprehensive Cancer Center and Faculty of Medicine, University Paris-South, F-94805, Villejuif, France. · Pubmed 28648698
  • The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, The Netherlands. Electronic address: · The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: · Department of Medical Oncology, Hospital Clínic Barcelona, Barcelona, Spain. Electronic address: · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany. Electronic address: · IRCCS San Martino-IST, Genova, Italy. Electronic address: · Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: · Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. Electronic address: · General University Hospital, Dermatooncology U, Prague, Czech Republic. Electronic address: · Chaim Sheba Medical Centre, Oncology Institute, Ramat-Gan, Israel. Electronic address: · Afdelingshoofd, Medische Oncologie, Brussels, Belgium. Electronic address: · Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany. Electronic address: · Oncology Institute of Veneto-IRCCS, Padova, Italy. Electronic address: · Papa Giovanni XIII Hospital, Bergamo, Italy. Electronic address: · University of Athens, Athens, Greece. Electronic address: · Hospital La Paz, Madrid, Spain. Electronic address: · University Medical Centre Groningen, Groningen, The Netherlands. Electronic address: · McGill University, Segal Cancer Centre, Montreal, Quebec, Canada. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: · Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia; Discipline of Medicine, University of Adelaide, Adelaide, Australia. Electronic address: · Pubmed 28501764
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne and University of Melbourne, Parkville, Australia. · AOU Senese Policlinico Santa Maria Alle Scotte, Siena, Italy. · Department of Medical Oncology, Hospital Clínic Barcelona, Spain. · Mount Vernon Hospital, Centre for Cancer Treatment, Northwood, UK. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · University Paris Descartes, Hospital Cochin, APHP, Paris, France. · Department of Dermatology, University Hospital Tuebingen, Tuebingen. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel. · Department of Dermatology, Comprehensive Cancer Center, University Hospital Essen, Essen, Germany. · Angeles Clinic and Research Institute, Los Angeles, USA. · Fachklinik Hornheide, Munster, Germany. · Moffitt Cancer Center, Tampa, USA. · Chaim Sheba Medical Centre, Oncology Institute, Ramat-Gan, Israel. · Crown Princess Cancer Centre Westmead Hospital and Department of Clinical Medicine, Macquarie University, Sydney NSW, Australia. · Seattle Cancer Care Alliance, Seattle, USA. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · University of Colorado Cancer Center, Aurora. · City of Hope, Duarte, USA. · Pubmed 27993793
  • Mario Sznol, Yale Comprehensive Cancer Center, New Haven, CT · Pier Francesco Ferrucci, Istituto Europeo di Oncologia, Milan · Massimo Guidoboni, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy · David Hogg, Princess Margaret Cancer Centre, Toronto, Ontario, Canada · Michael B. Atkins, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC · Pascal Wolter, University Hospitals Leuven, Leuven, Belgium · Celeste Lebbé, Université Paris Diderot, Paris · Luc Thomas, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France · John M. Kirkwood, Hillman Cancer Center, Pittsburgh, PA · Jacob Schachter, Sheba Medical Center, Ramat Gan, Israel · Gregory A. Daniels, University of California San Diego, Moores Cancer Center, La Jolla, CA · Jessica Hassel, University Hospital, Heidelberg, Germany · Jonathan Cebon, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria · Winald Gerritsen, University of Queensland, St Lucia · Victoria Atkinson, Gallipoli Medical Research Foundation, Greenslopes · Victoria Atkinson, Princess Alexandra Hospital, Brisbane, Queensland, Australia · Winald Gerritsen, Radboud University Medical Center, Nijmegen, the Netherlands · John McCaffrey, Irish Clinical Oncology Research Group, Dublin · Derek Power, Irish Clinical Oncology Research Group, Cork, Ireland · Dana Walker, Rafia Bhore, and Joel Jiang, Bristol-Myers Squibb, Princeton, NJ · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA · and Jedd D. Wolchok, Parker Institute and Ludwig Center at Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 28915085
2016
  • The Ella Lemelbaum Institute for Melanoma, Sheba Medical Center, 52621 Ramat-Gan, Israel. · Department of Clinical Microbiology & Immunology, Sackler School of Medicine, Tel Aviv University, 69978 Tel Aviv, Israel. · Pubmed 26653685
  • University Hospital Essen, Hufelandstrasse 55, D-45147 Essen, Germany. Electronic address: · Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091 Zurich, Switzerland. Electronic address: · Department of Dermatology, Venereology, and Allergology, University Hospital Schleswig-Holstein, Kiel Campus, Arnold-Heller Strasse 3, 24105 Kiel, Germany. Electronic address: · Gustave Roussy Cancer Campus and Paris-Sud University, 114 Rue Edouard Vaillant, 94800 Villejuif, France. Electronic address: · The Angeles Clinic and Research Institute, 2001 Santa Monica Blvd, Ste 560W, Santa Monica, CA 90404, USA. Electronic address: · University of California, San Francisco School of Medicine, 1600 Divisadero St, NZ Bldg A, San Francisco, CA 94115, USA. Electronic address: · Department of Medical Oncology, VU University Medical Center Amsterdam, De Boelelaan 1118, 1081 HZ Amsterdam, The Netherlands. Electronic address: · Department of Hematology/Oncology, University of Arizona Cancer Center at UMC North, 3838 N. Campbell Ave, Tucson, AZ 85724, USA. Electronic address: · The Los Angeles Skin Cancer Institute, The Beverly Hills Cancer Center, 8900 Wilshire Blvd, Beverly Hills, CA 90211, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, 2220 Pierce Ave, 777 Preston Research Building, Nashville, TN 37232, USA. Electronic address: · Department of Oncology, Ella Institute for Melanoma, Sheba Medical Center, Derech Sheba 2, Tel-Hashomer, Ramat-Gan, Israel. Electronic address: · Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Division of Medical Oncology, Duke Cancer Institute, Duke University Medical Center, Box 3198, 20 Duke Medicine Circle, Durham, NC 27710, USA. Electronic address: · Skin Clinic, Universitätsmedizin Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany. Electronic address: · Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08901, USA. Electronic address: · Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: · Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: · Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: · Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. Electronic address: · Department of Medicine, Division of Hematology-Oncology, Jonsson Comprehensive Cancer Center (JCCC) at the University of California, Los Angeles (UCLA), 10833 Le Conte Ave, Los Angeles, CA 90095, USA. Electronic address: · Pubmed 27596353
  • Ella Lemelbaum Institute of Melanoma, Sheba Medical Center, Ramat Gan, Israel. · Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Israel. · Talpiot Medical Leadership program, Sheba Medical Center, Ramat Gan, Israel. · Pubmed 26885752
2015
  • Ella Lemelbaum Institute for Melanoma, Division of Oncology, Sheba Medical Center, Tel Hashomer, Israel. · Pubmed 26065473
  • Service de Dermatologie, Aix Marseille University, and Assistance Publique Hôpitaux de Marseille (APHM), University Hospital Timone, Marseille, France. Electronic address: · GlaxoSmithKline Oncology Research and Development, Collegeville, PA, USA. · Przychodnia Lekarska Komed, Konin, Poland. · Sheba Medical Center, Ramat Gan, Ramat, Israel. · Department of Dermatology, Universität Zürich, Zurich, Switzerland. · Oncology Division, Poznan University of Medical Sciences, Med-Polonia, Poznan, Poland. · Moscow City Oncology Hospital #62, Stepanovskoye, Moscow, Russia. · Swissmed Centrum Zdrowia and Gdansk Medical University, Gdansk, Poland. · Centre Hospitalier Universitairede Reims-Hôpital Robert Debré, Reims, France. · Istituto Oncologico Veneto Istituto Di Ricovero e Cura a Carattere Scientifico, Padua, Italy. · Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. · N N Blokhin Russian Cancer Research Center, Moscow, Russia. · Petrov Research Institute of Oncology, Saint Petersburg, Russia. · University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium. · Universitätsklinikum Schleswig-Holstein (UKSH), Department of Dermatology, Kiel, Germany. · Melanoma Institute Australia, The University of Sydney and The Mater Hospital, Sydney, Australia. · Mount Vernon Cancer Centre, Northwood, UK. · University of California Los Angeles (UCLA) Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Department of Dermatology, University Hospital Essen, Essen, Germany. · Gustave Roussy, Département de Médecine oncologique, Service de Dermatologie et Université Paris-Sud, Faculté de Médecine, Villejuif, France. · Pubmed 26433819
  • University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · University of Zürich, Zürich, Switzerland. · University Hospital Essen, Essen, Germany. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Dana-Farber Cancer Institute, Boston, MA, USA. · Sheba Medical Center, Tel Hashomer, Israel. · New York University Cancer Institute, New York, NY, USA. · University of Colorado Denver, Aurora, CO, USA. · University of Arizona Cancer Center, Tucson, AZ, USA. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Italy. · Duke Cancer Institute, Durham, NC, USA. · Seattle Cancer Care Alliance/University of Washington, Seattle, WA, USA. · University Medical Center, Mainz, Germany. · Universitätsklinikum Tübingen, Tübingen, Germany. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, and Melanoma Institute Australia, Westmead, NSW, Australia. · St Luke's Cancer Center, Bethlehem, PA, USA; Temple University, Philadelphia, PA, USA. · University of North Carolina, Chapel Hill, NC, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Merck & Co, Kenilworth, NJ, USA. · University of California, San Francisco, San Francisco, CA, USA. · Pubmed 26115796
  • The Ella Lemelbaum Institute for Melanoma, Sheba Medical Center, 52621 Tel Hashomer, Israel. · The Ella Lemelbaum Institute for Melanoma, Sheba Medical Center, 52621 Tel Hashomer, Israel ; Talpiot Medical Leadership Program, Sheba Medical Center, 52621 Tel Hashomer, Israel. · The Ella Lemelbaum Institute for Melanoma, Sheba Medical Center, 52621 Tel Hashomer, Israel ; Talpiot Medical Leadership Program, Sheba Medical Center, 52621 Tel Hashomer, Israel ; Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, 69102 Tel Aviv, Israel. · Pubmed 26688824
  • Ella Institute of Melanoma Research, Sheba Medical Center, Ramat-Gan, Israel. · Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Talpiot Medical Leadership Program, Sheba Medical Center, Ramat-Gan, Israel. · Pubmed 26158900
  • Department of Surgery C, Chaim Sheba Medical Center, Tel Hashomer, Israel. · Ella Institute of Melanoma, Chaim Sheba Medical Center, Tel Hashomer, Israel. · Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 25573088
2014
  • Royal Marsden Hospital NHS Foundation Trust, London, UK. Electronic address: · Department of Medical Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy. · Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy. · Dermatooncology Department, General University Hospital, Prague, Czech Republic. · Ella Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel. · Universitair Ziekenhuis Brussel, Brussels, Belgium. · Service of Oncology-Hospital La Paz, Madrid, Spain. · Universität Tübingen-Hautklinik, Tübingen, Germany. · Melanoma Oncology Unit, Veneto Oncology Institute, Gattamelata, Padova, Italy. · Medical Oncology, University of Athens, Greece. · Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC, Canada. · Papa Giovanni XXIII Hospital, Bergamo, Italy. · Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands. · Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. · IRCCS San Martino Hospital-IST, Genoa, Italy. · University Hospital Schleswig-Holstein, Department of Dermatology, Kiel, Germany. · Cancer Clinical Trials Unit, Royal Adelaide Hospital, and Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia. · F Hoffmann-La Roche, Basel, Switzerland. · Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. Electronic address: · Pubmed 24582505
  • Ella Institute of Melanoma, Sheba Medical Center, Ramat-Gan, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Ella Institute of Melanoma, Sheba Medical Center, Ramat-Gan, Israel. · Institute of Pathology, Sheba Medical Center, Ramat-Gan 526260, Israel. · Cancer Research Center, Sheba Medical Center, Ramat-Gan, Israel. · Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Dermatology, Sheba Medical Center, Ramat-Gan, Israel. · The Susanne-Levy Gertner Oncogenetics Unit, Danek Gertner Institute of Human Genetics, Ramat-Gan, Israel. · Ella Institute of Melanoma, Sheba Medical Center, Ramat-Gan, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Talpiot Medical Leadership Program, Sheba Medical Center, Ramat-Gan, Israel. Electronic address: · Pubmed 24931667
  • Sheba Medical Center, Ella Institute of Melanoma, Ramat Gan, Israel Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Sheba Medical Center, Ella Institute of Melanoma, Ramat Gan, Israel. · Cancer Research Center, Ramat Gan, Israel. · Sheba Medical Center, Ella Institute of Melanoma, Ramat Gan, Israel Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel Talpiot Medical Leadership Program, Sheba Medical Center, Ramat Gan, Israel · Pubmed 24920276
2017
  • From the *Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel Hashomer; and †Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 28114254
2016
  • Departments of *Thoracic Surgery †Ella Lemelbaum Institute of Melanoma ‡General and Bariatric Surgery, Sheba Medical Center, Tel Hashomer §Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 27163742
2015
  • 1First Department of Medicine, Athens University Medical School, Athens, Greece; 2Division of Medical Oncology, Baskent University School of Medicine, Adana, Turkey; 3Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale Tumori Fondazione "G. Pascale," Naples, Italy; 4Department of Biotherapy, Blokhin Cancer Center, Moscow, Russia; 5Department of Dermatology, Medical University of Vienna, Vienna, Austria; 6Department of Dermatology, Institute Gustave Roussy, Villejuif Cedex, France; 7Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel; 8Department of Dermatologie, University of Kiel, Kiel, Germany; and 9Oncology Service, Hospital La Paz, Madrid, Spain. · Pubmed 24176884
2014
  • Department of Diagnostic Imaging, Sheba Medical Center, Tel-Hashomer, 2 Sheba Rd, Tel Hashomer 52621, Israel, affiliated to Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel, · Pubmed 24663820
2013
  • Ella Institute for Melanoma, Sheba Medical Center, 52621 Ramat-Gan, Israel. · Pubmed 23516145
  • Ella Institute for Melanoma, Sheba Medical Center, 52621 Ramat Gan, Israel. · Pubmed 23256800
  • Ella Institute of Melanoma, Department of Surgical Oncology, Sheba Medical Center, Ramat Gan, Israel. · Pubmed 23690483
  • Ella Institute of Melanoma, Sheba Medical Center , Ramat-Gan , Israel . · Pubmed 23902289
  • Ella Institute of Melanoma, Sheba Medical Center, Tel Hashomer, Israel. · Pubmed 23483943
  • Ella Institute of Melanoma, Sheba Medical Center, Ramat-Gan, Israel. · Pubmed 23451174
2012
  • Ella Institute for the Treatment and Research of Melanoma, Sheba Medical Center, Ramat-Gan, 52621, Israel. · Pubmed 22864561
  • Ella Institute for Melanoma, Sheba Medical Center, Ramat Gan 52621, Israel. · Pubmed 22778766
  • Department of Neurobiology, George S. Wise Faculty of Life Sciences, Tel Aviv University, 69978 Tel Aviv, Israel. · Pubmed 23028055
  • Ella Institute of Melanoma, Sheba Medical Center, Ramat-Gan, Israel. · Pubmed 22466331
  • The Ella Institute for Melanoma Research and Treatment, Cancer Research Center, Sheba Medical Center, 52621 Ramat Gan, Tel Hashomer, Israel. · Pubmed 22441657
2011
  • Ella Institute of Melanoma, Sheba Medical Center, Tel Hashomer, Israel. · Pubmed 21541354
  • Ella Institute for Treatment and Research of Melanoma, Sheba Medical Center, Tel-Hashomer, Israel. · Pubmed 21304398
2010
  • Ella Institute of Melanoma, Sheba Medical Center, Tel-Hashomer 52621, Israel. · Pubmed 21234353
  • Ella Institute of Melanoma, Sheba Medical Center, Tel-Hashomer, Israel. · Pubmed 20406835
  • The Ella Institute for Melanoma Research and Treatment, Sheba Cancer Research Center, Sheba Medical Center, 52621 Tel Hashomer, Israel. · Pubmed 19633846
2009
  • The Ella Institute for Treatment and Research of Melanoma, Sheba Medical Center, Tel-Hashomer, Israel. · Pubmed 19342963
  • Department of Surgery C & Surgical Oncology, Sheba Medical Center, Tel Hashomer, Israel. · Pubmed 20108553
  • Division of Oncology, Chaim Sheba Medical Center, Tel-Hashomer, Israel. · Pubmed 19455066
  • Department of Dermatology, Tel Aviv-Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 19443406
  • Ella Institute of Melanoma, Cancer Research Center, Sheba Medical Center, Ramat Gan, Israel. · Pubmed 19440333
  • Ella Institute of Melanoma, Sheba Medical Center, Tel-Hashomer, Israel. · Pubmed 19148842
Tel Aviv Sourasky Medical Center
2018
  • Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel. Electronic address: · Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Israel. · Division of Oncology, Sheba Medical Center, Ramat-Gan, Israel. · Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel. · Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel; Department of Oncology, Sackler Faculty of Medicine, Tel Aviv University, Israel. · Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Ramat-Gan, Israel; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Israel; Talpiot Medical Leadership Program, Sheba Medical Center, Ramat-Gan, Israel. · Pubmed 30096703
2017
  • The Ella Lemelbaum Institute of Immuno-oncology, Institute of Oncology, Sheba Medical Center, Tel Hashomer, Israel. · Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Talpiot Medical Leadership Program, Sheba Medical Center, Tel Hashomer, Israel. · Pubmed 28543698
  • Department of Surgery C, Chaim Sheba Medical Center, Ramat Gan, Israel. · Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Oncology, Chaim Sheba Medical Center, Ramat Gan, Israel. · Department of Surgery, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Pubmed 28650570
2015
  • Department of Surgery C, Chaim Sheba Medical Center, Tel Hashomer, Israel. · Ella Institute of Melanoma, Chaim Sheba Medical Center, Tel Hashomer, Israel. · Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 25573088
2017
  • From the *Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Tel Hashomer; and †Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 28114254
2016
  • Departments of *Thoracic Surgery †Ella Lemelbaum Institute of Melanoma ‡General and Bariatric Surgery, Sheba Medical Center, Tel Hashomer §Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 27163742
2014
  • Department of Diagnostic Imaging, Sheba Medical Center, Tel-Hashomer, 2 Sheba Rd, Tel Hashomer 52621, Israel, affiliated to Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel, · Pubmed 24663820
2009
  • Department of Dermatology, Tel Aviv-Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Pubmed 19443406
Miscellaneous institutions in Tel Aviv
2018
  • Ella Lemelbaum Institute for Immuno-Oncology, Ramat-Gan, 52621, Israel. · Sackler Faculty of Medicine, Department of Clinical Microbiology and Immunology, Tel Aviv, 69978, Israel. · Department of Cancer Biology, MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Pathology, Sheba Medical Center, Ramat Gan, 52621, Israel. · Ella Lemelbaum Institute for Immuno-Oncology, Ramat-Gan, 52621, Israel. · Sackler Faculty of Medicine, Department of Clinical Microbiology and Immunology, Tel Aviv, 69978, Israel. · Talpiot Medical Leadership Program, Sheba Medical Center, Ramat-Gan, 52621, Israel. · Pubmed 29855470
2013
Miscellaneous cities in Israel
2015
  • Ella Lemelbaum Institute of Melanoma, Sheba Medical Center, Israel. · Department of Clinical Microbiology and Immunology, Tel Aviv University, Tel Aviv, Israel. · cCAM Biotherapeutics, Misgav Industrial Park, Misgav, Israel. · Institute of Pathology, Sheba Medical Center, Israel. · Talpiot Medical Leadership Program, Sheba Medical Center, Israel. · Pubmed 26338962
2012
  • Ella Institute of Melanoma, Cancer Research Center, Sheba Medical Center 52621, Israel. · Pubmed 22196267
15 Other Locations Show
Yearly article counts 2610411496337
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.